$240,000 awarded to Dr. David Stellwagen at McGill University.

Project Details

Funding Amount

$240,000

Awardee

David Stellwagen

Host Institution

  • McGill University

Province |Quebec

Funding Program

Research Fund

Year Awarded |2013

Funding Partner

  • CIHR

Explore more funded projects.

View all

Untangle the endocannabinoid system alteration in ALS: a new therapeutic approach at the neuromuscular junction

Read news article

A multi-methods multi-site study of end-of-life care in individuals with ALS: goal concordance and caregiver perceptions

Read news article

Stress granules: neuroprotective or neurotoxic in ALS pathogenesis?

Read news article

We use cookies and other technologies to understand how you use our site and to improve your experience and provide you with valuable content. By continuing on this website, you consent to the use of these cookies. For more information and to opt-out of cookies, visit the cookie section of our privacy policy.